SHOP
logo
+1-4012094076
info@celnovte.com
En
EN CN
SHOP
2025 114th Annual Meeting of the Japanese Society of Pathology 2025-04-03
Top 10 Special Stains Every Dermatologist Should Know 2025-03-11
MOER >>

PRODUCTS

With proprietary intellectual property of MicroStacker™ and SuperISH™,

we have a market-leading portfolio of IHC and ISH reagents and instruments. 

SOLUTIONS

We provide Clinical Solutions, R&D Collaboration and OEM/ODM Partnership.

Distributor and OEM Partnership

Distributor and OEM Partnership
MicroStacker™ Ultra Polymer Detection Kit

MicroStacker™ Ultra Polymer Detection Kit
MicroStacker™ Mouse-on-Mouse Polymer Detection Kit

MicroStacker™ Mouse-on-Mouse Polymer Detection Kit

FACILITIES & CERTIFICATES

Our facilities in China are NMPA & GMP compliant

and certified for ISO13485 and ISO9001.

Manufactory Facilities
2025-04

Manufactory Facilities

Founded in 2010, Celnovte is headquartered in Zhengzhou, China for reagent and instrument development and manufacturing. It also has subsidiaries in Shenzhen for instrument R&D, in Suzhou for research-use product development, and in Maryland(USA) for reagent R&D. Our extensive medical instrument manufacturing facilities span 1000m² in Shenzhen, China, and 3000m² in Zhengzhou, China. We also have a GMP-certified lab at the class 10,000 and 100,000 levels, along with supporting research, production, and quality inspection equipment.
GMP Certified Lab
2025-03

GMP Certified Lab

The company has established a 10,000 square meters production workshop and research laboratory that complies with GMP standards. It has successfully passed the ISO9001 and ISO13485 system certifications.
ISO13485
2023-03

ISO13485

ISO13485
CE mark approval
2021-06

CE mark approval

Celnovte Biotechnology CE Approval
Celnovte PR NordiQC Assessment & Class III NMPA certificate
2021-06

Celnovte PR NordiQC Assessment & Class III NMPA certificate

Celnovte PR NordiQC Assessment, Class III NMPA certificate
Celnovte ER NordiQC Assessment & Class III NMPA certificate
2021-06

Celnovte ER NordiQC Assessment & Class III NMPA certificate

Celnovte self-cloned primary antibodies won optimal in NordiQC assessment for 6 consecutive years.
Celnovte got Class III NMPA certificate.
Celnovte HER2 NordiQC Assessment & Class III NMPA certificate
2021-06

Celnovte HER2 NordiQC Assessment & Class III NMPA certificate

Celnovte HER2 NordiQC Assessment & Class III NMPA certificate

NEWS

2025 114th Annual Meeting of the Japanese Society of Pathology
Top 10 Special Stains Every Dermatologist Should Know
Automated vs. Manual IHC Stainers: Time, Cost & Error Rates in High-Throughput Labs
VIEW MORE
top